HomeInsightsMarket Capitalization

Market Capitalization of Indoco Remedies Ltd

Market Capitalization of Indoco Remedies Ltd

stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

6.3 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Indoco Remedies Ltd

NSE: INDOCO

MARKETCAP

3407.52 crore

Last updated: 18 Sep 24

Key Highlights

  • The Market Cap of Indoco Remedies Ltd is ₹ 3407 crore as of 18 Sep 24.
  • The Market Cap of Indoco Remedies Ltd changed from ₹ 1867 crore on March 2019 to ₹ 3027 crore on March 2024 . This represents a CAGR of 8.38% over 6 years. .
  • The Latest Trading Price of Indoco Remedies Ltd is ₹ 369.65 as of 18 Sep 15:30.

Historical Market Cap of Indoco Remedies Ltd

No data available

* All values are in crore

Company Fundamentals for Indoco Remedies Ltd

No data available

Image

Indoco Remedies Ltd

NSE: INDOCO

PRICE

369.65

-5.95 (-1.58%)

stock direction

Last updated: 18 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Indoco Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 2024369.65
17 Sep 2024375.6
16 Sep 2024366.95
13 Sep 2024371.75
12 Sep 2024373
11 Sep 2024378.25
10 Sep 2024377.85
09 Sep 2024372.55
06 Sep 2024370.75
05 Sep 2024379.8

SWOT Analysis Of Indoco Remedies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Indoco Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Indoco Remedies Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Indoco Remedies Ltd

No data available

Historical P/E Ratio of Indoco Remedies Ltd

No data available

* All values are in %

Historical Revenue of Indoco Remedies Ltd

No data available

* All values are in crore

Historical EBITDA of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Net Profit of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Dividend Payout of Indoco Remedies Ltd

No data available

* All values are in %

About Indoco Remedies Ltd

  • Indoco Remedies Limited, incorporated as a Public Limited Company in August 23, 1947 is a Mumbai-based pharmaceutical company that focuses on formulations, with some presence in contract manufacturing and research.
  • The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
  • The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 166 million Company, employs over 6000 people including more than 300 skilled scientists.
  • The Company has 9 manufacturing facilities, 6 of which are for FDFs and 3 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility.
  • Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

Indoco Remedies Ltd News Hub

News

Indoco Remedies AGM scheduled

Indoco Remedies announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

31 Aug 202416:28

News

Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets

The generic equivalent of Lucemyra Tablets will market to USWM, LLC. 'Indoco has been gran...

Read more

21 Aug 202413:12

News

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg

Indoco Remedies announced the receipt of final approval from the USFDA for Abbreviated New...

Read more

21 Aug 202419:58

News

Indoco Remedies to conduct board meeting

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 23 July 20...

Read more

11 Jul 202409:31

News

Indoco Remedies receives USFDA approval for Canagliflozin and Metformin Hydrochloride Tablets

Indoco Remedies announced the receipt of tentative approval from the USFDA for Abbreviated...

Read more

07 Jun 202408:40

News

Indoco Remedies gains after receiving USFDA nod for type 2 diabetes drug

Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellit...

Read more

06 Jun 202414:47

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Indoco Remedies Ltd

What is the market cap of Indoco Remedies Ltd?

As of September 18, 2024, Indoco Remedies Ltd has a market capitalization of ₹3407.52, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Indoco Remedies Ltd's market capitalization?

Indoco Remedies Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Indoco Remedies Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Indoco Remedies Ltd's market capitalization change?

Indoco Remedies Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*